Washington State Opens Trial Against Albertsons Over Opioid Crisis, Seeking Damages
ACI is trading near its 52-week low of $13.165 (12% above the low).
Summary
Washington state began its trial against Albertsons on Monday, alleging the grocer's pharmacy practices fueled the opioid epidemic by overworking pharmacists and ignoring red flags. The state seeks unspecified damages and penalties, having opted out of the company's $774 million nationwide settlement announced in April. Opening statements accused Albertsons of prioritizing profits over safety, with the trial expected to run through September. This follows the April 10-K disclosure of the opioid settlement charge and adds a new, unresolved legal front that could result in significant additional liability. The outcome may set a precedent for other states that did not join the nationwide deal.
At the time of this announcement, ACI was trading at $14.73 on NYSE in the Trade & Services sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $13.17 to $22.39. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.